Kashanchi F - Search Results

1

Use of ATP analogs to inhibit HIV-1 transcription.

Narayanan A, Sampey G, Van Duyne R, Guendel I, Kehn-Hall K, Roman J, Currer R, Galons H, Oumata N, Joseph B, Meijer L, Caputi M, Nekhai S, Kashanchi F. Narayanan A, et al. Among authors: kashanchi f. Virology. 2012 Oct 10;432(1):219-31. doi: 10.1016/j.virol.2012.06.007. Epub 2012 Jul 6. Virology. 2012. PMID: 22771113 Free PMC article.

2

Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs.

Kashanchi F, Sadaie MR, Brady JN. Kashanchi F, et al. Virology. 1997 Jan 20;227(2):431-8. doi: 10.1006/viro.1996.8346. Virology. 1997. PMID: 9018142 Free article.

3

Inhibition of human immunodeficiency virus type 1 transcription by chemical cyclin-dependent kinase inhibitors.

Wang D, de la Fuente C, Deng L, Wang L, Zilberman I, Eadie C, Healey M, Stein D, Denny T, Harrison LE, Meijer L, Kashanchi F. Wang D, et al. Among authors: kashanchi f. J Virol. 2001 Aug;75(16):7266-79. doi: 10.1128/JVI.75.16.7266-7279.2001. J Virol. 2001. PMID: 11461999 Free PMC article.

4

HIV-1 Tat interaction with RNA polymerase II C-terminal domain (CTD) and a dynamic association with CDK2 induce CTD phosphorylation and transcription from HIV-1 promoter.

Deng L, Ammosova T, Pumfery A, Kashanchi F, Nekhai S. Deng L, et al. Among authors: kashanchi f. J Biol Chem. 2002 Sep 13;277(37):33922-9. doi: 10.1074/jbc.M111349200. Epub 2002 Jul 11. J Biol Chem. 2002. PMID: 12114499 Free article.

5

Coordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcription.

Zhou M, Deng L, Lacoste V, Park HU, Pumfery A, Kashanchi F, Brady JN, Kumar A. Zhou M, et al. Among authors: kashanchi f. J Virol. 2004 Dec;78(24):13522-33. doi: 10.1128/JVI.78.24.13522-13533.2004. J Virol. 2004. PMID: 15564463 Free PMC article.

6

RNA interference directed to CDK2 inhibits HIV-1 transcription.

Ammosova T, Berro R, Kashanchi F, Nekhai S. Ammosova T, et al. Among authors: kashanchi f. Virology. 2005 Oct 25;341(2):171-8. doi: 10.1016/j.virol.2005.06.041. Epub 2005 Aug 8. Virology. 2005. PMID: 16085226 Free article.

7

Nuclear targeting of protein phosphatase-1 by HIV-1 Tat protein.

Ammosova T, Jerebtsova M, Beullens M, Lesage B, Jackson A, Kashanchi F, Southerland W, Gordeuk VR, Bollen M, Nekhai S. Ammosova T, et al. Among authors: kashanchi f. J Biol Chem. 2005 Oct 28;280(43):36364-71. doi: 10.1074/jbc.M503673200. Epub 2005 Aug 29. J Biol Chem. 2005. PMID: 16131488 Free article.

8

Inhibition of HIV-1 virus replication using small soluble Tat peptides.

Agbottah E, Zhang N, Dadgar S, Pumfery A, Wade JD, Zeng C, Kashanchi F. Agbottah E, et al. Among authors: kashanchi f. Virology. 2006 Feb 20;345(2):373-89. doi: 10.1016/j.virol.2005.09.062. Epub 2005 Nov 14. Virology. 2006. PMID: 16289656 Free article.

9

Acetylated Tat regulates human immunodeficiency virus type 1 splicing through its interaction with the splicing regulator p32.

Berro R, Kehn K, de la Fuente C, Pumfery A, Adair R, Wade J, Colberg-Poley AM, Hiscott J, Kashanchi F. Berro R, et al. Among authors: kashanchi f. J Virol. 2006 Apr;80(7):3189-204. doi: 10.1128/JVI.80.7.3189-3204.2006. J Virol. 2006. PMID: 16537587 Free PMC article.

10

Potential use of pharmacological cyclin-dependent kinase inhibitors as anti-HIV therapeutics.

Pumfery A, de la Fuente C, Berro R, Nekhai S, Kashanchi F, Chao SH. Pumfery A, et al. Among authors: kashanchi f. Curr Pharm Des. 2006;12(16):1949-61. doi: 10.2174/138161206777442083. Curr Pharm Des. 2006. PMID: 16787240 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

261 results

Search Page